Recent studies have shown that SNHG16 exacerbates diabetic nephropathy by stabilizing TLR4 to regulate RAS and NF-κB pathway-mediated NLRP3 inflammatory vesicle activation [25]. Here, TLR4 is linked to diabetic kidney disease.